Login / Signup

Development and validation of a product acceptability questionnaire for intranasal Q-Griffithsin COVID-19 prophylaxis (SPRAY PAL).

Elizabeth D CashKailyn DeitzKevin L PottsHenry W NabetaMaryam ZahinShesh N RaiGerald W DrydenKenneth E Palmer
Published in: BMJ open (2023)
NCT05122260 and NCT05437029.
Keyphrases
  • coronavirus disease
  • sars cov
  • cross sectional